图像引导下肌肉骨骼粗针活检前省略常规出血检查的安全性
本研究评估肌肉骨骼粗针活检前省略凝血酶原时间国际标准化比值和血小板检测的安全性。第一阶段回顾性分析1162例有术前检测的患者,出血并发症率2.6%,无出血并发症患者术前出血检测异常;第二阶段188例未行术前凝血检测,出血并发症率1.1%。结论认为肌肉骨骼活检出血并发症低,即使省略术前凝血检测亦然。
要点
- 肌肉骨骼粗针活检出血并发症率低,有术前检测组为2.6%,未检测组为1.1%。
- 软组织病变和超声引导下活检的出血率分别高于骨病变和CT引导下活检。
- 有出血并发症的患者术前出血检测均无异常。
核心结论
- 肌肉骨骼活检出血并发症低,即使省略术前凝血检测亦然。
研究设计与样本
- 第一阶段为回顾性审查,纳入1162例连续接受肌肉骨骼粗针活检并做术前INR和血小板检测的患者;第二阶段研究188例未做术前凝血检测的活检。采用卡方检验或Fisher精确检验比较分类变量,Student t检验比较连续变量,logistic回归进行多因素分析。
关键影像表现/征象
- 软组织病变活检出血率高于骨病变(p=0.029)。
- 超声引导下活检出血率高于CT引导下活检(p=0.048)。
诊断标准与关键数值
- 第一阶段出血并发症率为2.6%(30/1162)。
- INR>2者仅3例,占0.3%(3/1162);血小板计数<50,000/ul者仅4例,占0.3%(4/1162)。
- 有出血并发症的患者均无术前出血检测异常。
- 第二阶段出血并发症率为1.1%(2/188)。
临床应用与阅片要点
- 肌肉骨骼粗针活检出血并发症低,省略术前INR和血小板检测后出血并发症率仍低。
- 软组织病变和超声引导下活检的出血风险相对较高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the safety of withholding preprocedure international normalized ratio (INR) and platelet testing in patients undergoing musculoskeletal (MSK) core needle biopsy (CNB).
MATERIAL AND METHODS: Initially, a retrospective review of 1,162 consecutive patients undergoing MSK CNB with preprocedural INR and platelet testing was performed. Clinical (age, gender, bleeding disorder, liver disease, anticoagulation use, INR > 2, platelet count <50,000/ul) and biopsy factors (imaging modality, lesion type, biopsy needle gauge, number biopsy samples) were tested for association with bleeding complications. During the second phase, an additional 188 biopsies performed without preprocedural coagulation testing were studied. Categorical variables were compared using Chi-squared or Fisher's exact tests, continuous variables with a student t-test. Multivariate analysis was performed using logistic regression.
RESULTS: In the first phase, there was a complication rate of 2.6%, 30/1162. Of the 11 clinical and biopsy factors, soft tissue lesions (p = 0.029) and lesions biopsied under ultrasound (p = 0.048) had a higher rate of bleeding than bone lesions or lesions biopsied under CT, respectively. Only three patients had an INR >2, 0.3% (3/1162) and only four patients had platelet count <50,000/ul, 0.3% (4/1162). No patient with a bleeding complication had an abnormal preprocedure bleeding test. In the second phase, there was a bleeding complication rate of 1.1% (2/188).
CONCLUSION: Bleeding complications from MSK biopsy are low, even when preprocedure coagulation testing is omitted.
引用
- Shif Y, Kung JW, McMahon CJ, et al. Safety of omitting routine bleeding tests prior to image-guided musculoskeletal core needle biopsy. Skeletal Radiol. 2017. PMID: 28983679. doi:10.1007/s00256-017-2784-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。